At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 86 enrolled
Drug / intervention
NeilMed sinus rinse +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The HVSI STUDY: High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial
Samuel Lunenfeld Research Institute, Mount Sinai Hospital·interventional·Posted Apr 11, 2012·Updated Apr 23, 2014
In Brief
A Phase 4 clinical trial evaluating NeilMed sinus rinse and Salinex for Chronic Rhinosinusitis. Completed, enrolled 86 participants across 4 sites.
Detailed Summary
Purpose: To determine if high volume saline nasal irrigation (HVSI), (NeilMed® Sinus Rinse™) offers a benefit over low volume saline irrigation (LVSI), (Salinex®) in the early post-operative management in patients with chronic rhino sinusitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Rhinosinusitis
CountriesCanada
CollaboratorsNeilMed Pharmaceuticals
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedApr 2012
Primary CompletionApr 2014
TodayJul 2026
First PostedApr 11, 2012
Enrollment StartMar 1, 2012
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.2 years ago
Interventions
NeilMed sinus rinsedevice
High volume saline irrigation
Salinexdevice
Low volume saline irrigation